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Chronic inflammation is an important conse-
quence of obesity that impacts upon the develop-
ment of insulin resistance, diabetes, and metabolic 
syndrome (Hotamisligil, 2006; Neels and Olefsky, 
2006). Obesity-induced systemic inflammation 
is characterized by chronic elevations in circu-
lating inflammatory cytokines (e.g., TNF and 
IL-6), adipokines, and monocytes (Hotamisligil 
et al., 1995; Ghanim et al., 2004). At the tissue 
level, inflammatory pathways are induced in 
visceral adipose tissue that lead to a striking ac-
cumulation of macrophages (Weisberg et al., 
2003; Xu et al., 2003). These adipose tissue mac-
rophages (ATMs) are now recognized to be a 
significant participant in the inflammatory re-
sponse to obesity as they generate a wide range 
of inflammatory cytokines in hypertrophied 
adipose tissue (Coppack, 2001). Attenuation 
of inflammatory genes such as Jnk1 and Ikkb in 
macrophages has been shown to decrease in-
flammation and prevent the development of 
insulin resistance and glucose intolerance with 
diet-induced obesity (DIO; Arkan et al., 2005; 
Solinas et al., 2007). Signals between inflam-
matory ATMs and adipocytes impair insulin 
sensitivity in adipocytes and influence adipo-
cyte cell death (Cinti et al., 2005; Lumeng   
et al., 2007a).
The  biology  of  ATMs  in  both  lean  and 
obese states is slowly being revealed. ATMs are 
derived from the bone marrow and differentiate 
in adipose tissue from circulating monocytes 
(Weisberg et al., 2003). Two distinct types of 
ATMs have been identified. ATMs in obese mice 
have an activation pattern similar to that seen 
with classical or M1 macrophage activation, with 
high expression of Tnfa, Il6, and Nos2 (Lumeng 
et al., 2007b). We will refer to these cells as 
type  1  ATMs  and  define  them  as  F4/80+ 
CD11c+ macrophage galactose-type C-type 
lectin 1 (MGL1; Lumeng et al., 2007b, 2008; 
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Adipose tissue macrophages (ATMs) play a critical role in obesity-induced inflammation and 
insulin resistance. Distinct subtypes of ATMs have been identified that differentially express 
macrophage galactose-type C-type lectin 1 (MGL1/CD301), a marker of alternatively 
activated macrophages. To evaluate if MGL1 is required for the anti-inflammatory function 
of resident (type 2) MGL1+ ATMs, we examined the effects of diet-induced obesity (DIO) 
on inflammation and metabolism in Mgl1/ mice. We found that Mgl1 is not required for 
the trafficking of type 2 ATMs to adipose tissue. Surprisingly, obese Mgl1/ mice were 
protected from glucose intolerance, insulin resistance, and steatosis despite having more 
visceral fat. This protection was caused by a significant decrease in inflammatory (type 1) 
CD11c+ ATMs in the visceral adipose tissue of Mgl1/ mice. MGL1 was expressed specifi-
cally in 7/4hi inflammatory monocytes in the blood and obese Mgl1/ mice had lower 
levels of 7/4hi monocytes. Mgl1/ monocytes had decreased half-life after adoptive trans-
fer and demonstrated decreased adhesion to adipocytes indicating a role for MGL1 in the 
regulation of monocyte function. This study identifies MGL1 as a novel regulator of inflam-
matory monocyte trafficking to adipose tissue in response to DIO.
© 2009 Westcott et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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We sought to examine the role of MGL1 in obesity-
induced inflammation and insulin resistance by evaluating the 
response of Mgl1/ mice to DIO. We hypothesized that the 
protective functions of type 2 ATMs would be attenuated 
in Mgl1/ mice, and that they would show increased in-
flammation and worse insulin resistance. Surprisingly, we 
observed the opposite result as obese Mgl1/ mice had im-
proved glucose tolerance and impaired accumulation of type 1 
ATMs in visceral adipose tissue. The mechanism of this ef-
fect is related to the expression of MGL1 on inflammatory 
7/4hi monocytes and the lack of maintenance of these mono-
cytes in the circulation caused by the intrinsic properties of 
Mgl1/ monocytes. Overall, we demonstrate that MGL1 
is a novel cell surface receptor involved in the regulation 
of monocyte/macrophage activation and trafficking to fat 
in obesity.
RESULTS
Type 2 ATMs do not require MGL1 to traffic properly  
to adipose tissue
We have previously shown that the resident population of 
type 2 ATMs expresses high levels of MGL1 (Lumeng et al., 
2008). We hypothesized that MGL1 might participate in the 
recruitment of these ATMs to fat. To test this, we examined 
ATMs from Mgl1/ mice fed a normal chow diet (ND) by 
immunofluorescence. ATMs were present in Mgl1/ mice 
with a morphology and density that was identical to WT 
controls (Fig. 1 A). ATMs in Mgl1/ and WT mice ex-
pressed CX3CR1 and the M2 macrophage marker, CD206/
mannose receptor. Quantitation of ATMs in epididymal fat 
pads from ND mice by flow cytometry showed no difference 
in the quantity of F4/80+ CD206+ ATMs between Mgl1/ 
mice and WT controls (Fig. 1 B). We also found that type 2 
ATMs in lean mice from both genotypes express ST2 (Fig. 1 C), 
a member of the TLR-IL receptor superfamily that nega-
tively regulates TLR4 signaling (Brint et al., 2004). Similar 
to MGL1, ST2 expression is restricted to type 2 ATMs in in-
terstitial spaces of adipose tissue from obese mice and is not 
expressed in inflammatory type 1 ATMs in CLS (Isolectin+; 
Fig.  1  D).  MGL1  staining  confirmed  the  lack  of  MGL1   
expression in Mgl1/ mice, and demonstrated specificity 
of the antibody for MGL1 (Fig. 1 C). Overall, these results 
demonstrate that MGL1 is not required for the proper lo-
calization and antiinflammatory characteristics of resident 
type 2 ATMs.
High-fat diet (HFD)-fed Mgl1/ mice show slight 
protection from DIO by HFD feeding
Although MGL1 does not influence the phenotype of resident 
ATMs in lean mice, we hypothesized that Mgl1 deficiency 
might alter inflammation and insulin resistance in the context 
of DIO. Therefore, we placed Mgl1/ and control mice on a 
HFD for 18 wk. Mgl1/ mice gained weight at a similar rate 
as WT controls until the last weeks of the HFD feeding when 
the weight of Mgl1/ mice was slightly reduced compared 
with controls (Fig. 2 A). There were no differences in weight 
Nguyen et al., 2007). Type 1 ATMs organize themselves 
into clusters that have been described as “crownlike structures” 
(CLSs) that are closely coupled to adipocyte death (Cinti et al., 
2005; Murano et al., 2008). These ATMs ingest triglyceride 
and take on an appearance similar to foam cells (Cinti et al., 
2005; Lumeng et al., 2007a).
A second population of ATMs has the phenotype F4/80+ 
CD11c MGL1+; we will refer to these as type 2 ATMs 
(Lumeng et al., 2008). These ATMs are the predominant 
macrophage type in adipose tissue in lean mice and express genes 
that overlap with alternatively activated or M2 macrophages, 
such as Arg1, Il10, Mgl1, and Mgl2 (Lumeng et al., 2007b). 
Type 2 ATMs localize in interstitial spaces between adipocytes 
and are present in both lean and obese states. It is believed that 
the alternative activation state of type 2 ATMs maintains ho-
meostasis by suppressing proinflammatory signals activated with 
obesity as macrophage-specific knockouts of Pparg and Ppard 
demonstrate worse insulin resistance and inflammation (Hevener 
et al., 2007; Odegaard et al., 2007; Kang et al., 2008).
Type 2 ATMs predominate in lean mice, whereas obesity 
induces the accumulation of type 1 ATMs leading to a proin-
flammatory environment (Lumeng et al., 2007b). The mecha-
nism behind this shift in ATM phenotype may relate to the 
differential recruitment of monocyte subtypes to adipose tis-
sue (Weisberg et al., 2006; Gordon, 2007; Lumeng et al., 
2008; Nishimura et al., 2008). In mice, a population of 7/4hi 
CCR2+ Ly-6Chi CX3CR1lo monocytes are preferentially re-
cruited to sites of tissue inflammation and generate classically 
activated macrophages (Gordon and Taylor, 2005; Gordon, 
2007). In contrast, 7/4mid CCR2 Ly-6Clo CX3CR1hi mono-
cytes appear to be regulated by different stimuli and may play 
a role in patrolling noninflamed tissues that give rise to resi-
dent tissue macrophages (Geissmann et al., 2003; Auffray et al., 
2007; Bouhlel et al., 2007; Charo, 2007). Importantly, 7/4hi 
monocytes are increased with obesity, suggesting that they may 
be a specific inflammatory mediator of obesity-induced inflam-
mation (Tsou et al., 2007).
Type 2 ATMs express high levels of macrophage galactose-
type C lectin 1 (MGL1/CD301), a marker of alternatively 
activated macrophages (Kang et al., 2008; van Kooyk, 2008). 
MGL1 is type 2 transmembrane protein expressed on macro-
phages and DCs in multiple tissues that is part of a family of 
scavenger receptors including macrophage mannose receptor 
(CD206; van Kooyk, 2008; van Vliet et al., 2008a). Func-
tions for mMGL1, its homologue mMGL2, and human MGL 
in DCs include antigen presentation, suppression of effector 
T cell function, and negative regulation of cell migration (van 
Vliet et al., 2006, 2008a, 2008b). mMGL1 has binding speci-
ficity for Lewis X and Lewis A structures, which differenti-
ates it from mMGL2 and hMGL (Tsuiji et al., 2002; Singh et al., 
2009). MGL1 ligands include sialoadhesin, apoptotic cells, and 
commensal bacteria such as Streptococcus sp. (Kumamoto et al., 
2004; Yuita et al., 2005; Saba et al., 2009). This latter interac-
tion triggers production of IL-10 in macrophages and explains 
the increased inflammation seen with experimental colitis in 
Mgl1/ mice (Saba et al., 2009).JEM VOL. 206, December 21, 2009 
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tection from long-term HFD feeding, but had a greater ac-
cumulation of visceral fat compared with controls.
MGL1 plays a role in DIO-induced insulin resistance  
and glucose intolerance
Glucose metabolism was evaluated in ND and HFD-fed 
Mgl1/ and WT mice. HFD-fed mice from both genotypes 
demonstrated fasting hyperglycemia compared with ND-fed 
mice, and there were no significant differences between gen-
otypes (Fig. 3 A). Fasting insulin levels were elevated in 
HFD-fed mice compared with lean controls with a trend to-
ward increased insulin levels in knockout versus WT controls 
(Fig. 3 B; P = 0.2). Glucose tolerance tests showed no differ-
ences between lean ND-fed Mgl1/ and controls (Fig. 3 C). 
However, obese Mgl1/ mice had significantly improved 
glucose tolerance compared with HFD-fed controls. Insulin 
tolerance tests demonstrated that HFD Mgl1/ mice were 
significantly more insulin sensitive than obese Mgl1+/+ mice 
with a profile similar to ND mice (Fig. 3 D). These data show 
between ND-fed Mgl1/ and Mgl1+/+ mice (Fig. 2 B). No 
significant difference in food intake was observed between 
Mgl1/ mice and control mice that could explain the slight 
weight difference (Fig. 2 C). Respiratory quotient was also 
similar between the two genotypes (Figs. 2 D). A small, but 
statistically significant increase in oxygen consumption was 
seen in HFD-fed Mgl1/ mice, but this lost significance when 
corrected for lean body mass (Fig. 2 E).
Body composition analysis showed that HFD-fed Mgl1/ 
mice had less fat mass compared with controls, and this pri-
marily accounted for the difference in weight (Fig. 2 F). Ex-
amination of the tissue weights showed that Mgl1/ mice 
had less subcutaneous white adipose tissue (inguinal fat pad) 
and lower liver weight. When expressed as a percentage of 
total body weight, liver weight was significantly decreased in 
Mgl1/ mice. Surprisingly, obese Mgl1/ mice had a dif-
ferent distribution of fat, with relatively more visceral white 
adipose tissue (epididymal fat pad) than HFD-fed control 
mice (Fig. 2 G). Overall, Mgl1/ mice showed slight pro-
Figure 1.  Type 2 ATMs are unchanged in lean Mgl1/ mice. (A) Analysis of ATMs in lean mice for markers of alternative activation. Epididymal 
white adipose tissue (EWAT) from lean Mgl1/ and Mgl1+/+ mice were stained for CD206 and CX3CR1. (B) Quantitation of F4/80+ CD206+ ATMs in lean 
Mgl1/ and Mgl1+/+ mice. SVF isolated from EWAT (n = 4) and analyzed by flow cytometry. Total ATM numbers were normalized to tissue mass. (C) ST2 
expression in type 2 resident ATMs. EWAT from ND-fed Mgl1/ and control C57BL/6 mice were stained for ST2 (green) and MGL1 (red). Staining and 
imaging parameters were identical between samples to demonstrate the specificity of the antibodies for MGL1. (D) ST2 expression in obese mice. Isolectin 
staining identifies CLSs containing type 1 ATM clusters. Samples from EWAT from HFD-fed C57BL/6 mice. (A, C, and D) Representative images shown from 
one of at least three independent experiments. Bars, 50 µm.3146 MGL1 and obesity-induced inflammation | Westcott et al.
more visceral fat than controls correlating with more exten-
sive adipocyte hypertrophy and less ATM accumulation.
These observations suggested that Mgl1/ mice are more 
efficient at storing lipid in adipose tissue with HFD. Analysis 
of serum-free fatty acid (FFA) levels confirmed that Mgl1/ 
mice had lower circulating levels of FFAs than obese controls 
(Fig. 3 G). Furthermore, liver histology demonstrated that 
Mgl1/ mice were protected from hepatic steatosis induced 
by HFD feeding, a finding that likely explains the difference 
in liver mass between the genotypes (Fig. 3 H). Overall, this 
demonstrates that obese Mgl1/ mice have more efficient 
that Mgl1/ deficiency leads to improved glucose tolerance 
and insulin sensitivity with DIO.
The protection from insulin resistance in Mgl1/ mice 
occurred in spite of the fact that Mgl1/ mice have propor-
tionately more visceral fat. Examination of visceral adipose 
tissue showed that obese Mgl1/ had more intact adipo-
cytes and fewer macrophage-containing CLS compared with 
HFD-fed Mgl1+/+ controls (Fig. 3 E). Analysis of adipocyte 
size demonstrated that obese Mgl1/ mice had significantly 
larger adipocytes compared with obese controls (Fig. 3 F). 
Overall, the data showed that HFD-fed Mgl1/ mice had 
Figure 2.  Effect of DIO on Mgl1/ mice. (A) Weight gain in HFD-fed Mgl1/ and control mice. Mice fed a diet of 60% kcal from fat. *, P < 0.05.  
n = 6 per genotype. (B) Total body weights of ND and HFD-fed mice. *, P = 0.049; #, P < 0.0001 versus ND. n = 10 mice per group. (C–F) Metabolic param-
eters of HFD-fed mice. *, P < 0.05. n = 6 per group. CLAMS unit used to measure food intake (C), respiratory quotient (D), and oxygen consumption (E) in 
HFD-fed mice. VO2 data shown with and without normalization for lean body weight (LBW). (F) Body composition analysis of HFD-fed mice measured 
with MRI and corrected for body weight. (G) Tissue weights in HFD-fed mice. Tissue weight with and without normalization to total body weight is pre-
sented. *, P < 0.05 versus WT. n = 9 mice per genotype. Results combined from 2 independent sets of animals.JEM VOL. 206, December 21, 2009 
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Figure 3.  Mgl1/ mice are protected from DIO-induced insulin resistance. Fasting glucose levels (A) and insulin levels (B). *, P < 0.05. n = 9–12 
per group. (C) Glucose tolerance test. Glucose levels were measured after i.p. injection of 0.7 g/kg glucose. *, P < 0.05 versus Mgl1+/+. n = 10 per group 
from two independent experiments. (D) Insulin tolerance test. Glucose levels were measured after i.p. injection of 1 U/kg insulin. *, P < 0.05 versus 
Mgl1+/+. n = 6 per group from two independent experiments. (E) Hematoxylin and eosin (H&E)–stained sections from epididymal adipose tissue from 
mice. Representative images shown. Similar results seen in four independent samples. (F) Adipocyte sizing from visceral adipose tissue. Adipocyte cross-
sectional area was assessed on H&E sections by analysis of 150 adipocytes per mouse from 3 separate sections and 3–4 mice per group. **, P < 0.0001. 
(G) FFA levels. Fasting serum was collected and analyzed for nonesterified FFA levels. **, P < 0.0001. n = 6–8 mice per group. (H) H&E-stained sections 
from liver biopsies from mice. Representative images shown. Similar results seen in four independent samples.3148 MGL1 and obesity-induced inflammation | Westcott et al.
increased in HFD-fed Mgl1/ mice compared with controls. 
Overall, our data suggest that the improved glucose and insulin 
tolerance in Mgl1/ mice is related to a decrease in the accu-
mulation of type 1 inflammatory ATMs in visceral adipose tis-
sue, less adipose tissue inflammation, less systemic inflammation, 
and more intact adipocytes, which led to less hepatic steatosis.
7/4hi inflammatory monocytes express MGL1 and are not 
induced by DIO in Mgl1/ mice
The prior results were unexpected, as it appeared that MGL1 
was required for the accumulation of type 1 ATMs with low 
MGL1 expression. Additionally, despite elevated levels of 
CCL2 in obese Mgl1/ mice, ATM trafficking to fat was 
not increased and was, in fact, suppressed. We hypothesized 
that these observations might relate to an undescribed role for 
MGL1 in monocytes in the bone marrow or blood that give 
rise to ATMs. To evaluate this, we examined the quantity of 
7/4hi and 7/4mid monocytes, monocyte subclasses with differ-
ent inflammatory functions, in the blood of Mgl1/ and 
Mgl1+/+ mice on different diets (Fig. 5 A). In ND mice, 
Mgl1/ mice had similar amounts of 7/4hi monocytes com-
pared with controls, but had an increased percentage of 7/4mid 
monocytes in the blood. Similar to other studies (Tsou et al., 
2007), we observed an increase in circulating 7/4hi monocytes in 
control mice with HFD. However, in Mgl1/ mice, DIO 
did not induce an increase in 7/4hi inflammatory monocytes. 
7/4mid monocytes were not significantly different between 
HFD-fed Mgl1/ and control mice. Examination of 7/4hi and 
7/4mid monocytes in the bone marrow demonstrated no sig-
nificant differences in the monocyte subclasses between Mgl1/ 
and control mice (Fig. 5 B).
These results suggest that MGL1 plays a role in the induc-
tion and/or maintenance of circulating 7/4hi monocytes in 
response to DIO that ultimately attenuates the accumulation 
of type 1 inflammatory ATMs. Consistent with this, we found 
that MGL1 was expressed only on 7/4hi monocytes and not on 
7/4mid monocytes in lean animals (Fig. 5, C and D). HFD ex-
posure induced low MGL1 expression in 7/4mid monocytes.
Mgl1 regulates monocyte half-life in the circulation  
and is required for maximal macrophage recruitment  
to sites of inflammation
The identification of MGL1 expression on monocytes sug-
gests that MGL1 deficiency alters the properties of circulating 
monocytes. This would provide a mechanism to explain the 
decrease in 7/4hi monocytes in the blood, but not the bone 
marrow, of knockout mice. It can also explain the attenua-
tion of ATM accumulation in visceral fat despite adipocyte 
hypertrophy. To assess this, we performed adoptive transfer ex-
periments to compare the circulating half-life of monocytes 
from wild-type and Mgl1/ mice. CFSE-labeled monocytes 
from the two genotypes were injected IV into C57BL/6 re-
cipients and circulating CD11b+ monocytes were quantified 
in the blood 24 and 72 h after injection. This demonstrated 
that fewer monocytes were recovered from the circulation 
after transfer of Mgl1/ cells compared with control cells at 
lipid storage in adipose tissue compared with controls, thus 
providing protection from fatty liver.
Mgl1 is required for the accumulation of proinflammatory 
type 1 ATMs with DIO
The adipose tissue histology suggested that alterations in 
ATM-induced inflammation might explain the protection 
from insulin resistance in obese Mgl1/ mice. Examination 
of inflammatory gene expression in epididymal adipose tissue 
showed that obese Mgl1/ mice had significantly more Il10 
expression compared with controls (Fig. 4 A). Il10 expression 
was not altered in the inguinal fat pads from the Mgl1/ 
mice, suggesting that Mgl1 deficiency primarily effects visceral 
fat inflammation. No other significant differences in inflam-
matory gene expression were seen between genotypes, although 
there was a trend toward a decrease in Itgax/Cd11c expression 
and an increase in Cx3cr1 expression in Mgl1/ mice. Mgl2 
expression was not changed in adipose tissue with Mgl1 defi-
ciency, demonstrating that this orthologue is not up-regulated 
to compensate for the lack of MGL1. No significant differ-
ences in gene expression were seen in inguinal (subcutaneous) 
fat (Fig. 4 B).
Because type 2 ATMs are a source of IL-10 in adipose 
tissue (Lumeng et al., 2008), we hypothesized that obese 
Mgl1/ mice may have an altered ratio of type 1 to type 2 
ATMs. To test this, we evaluated ATM content in obese mice 
by flow cytometry using markers of type 1 (CD11c) and type 2 
(CD206) ATMs (Fig. 4 C; Nguyen et al., 2007). Although 
the percentage of F4/80+ CD11b+ ATMs in Mgl1/ mice 
was similar to controls, the total number of ATMs isolated 
from epididymal fat pads was slightly decreased. The content 
of CD11c+ ATMs in obese Mgl1/ mice was reduced to 
40% of WT levels that persisted with normalization to fat 
weight. This resulted in an overall reduction in the ratio of 
type 1 to type 2 (CD11c+/CD206+) ATMs in HFD-fed Mgl1/ 
mice (Fig. 4 D). CD206 staining was not different between 
ATMs from Mgl1/ mice and controls, demonstrating that 
the expression of this lectin is also not altered in the absence 
of MGL1.
Immunofluorescence microscopy of epididymal fat pads 
supported the flow cytometry data. There was a significant 
decrease in the number of type 1 ATM clusters in fat from 
Mgl1/ mice compared with Mgl1+/+ controls (Fig. 4 E). This 
protection from type 1 ATM accumulation was more striking 
with long-term HFD exposure (26 wk) as Mgl1/ mice had 
very few Mac2+ CLS compared with controls (Fig. 4 F). Com-
posite images demonstrated that CLS were not uniformly dis-
tributed in epididymal fat pads in HFD-fed WT mice.
To evaluate the effects of MGL1 deficiency on systemic 
inflammation in obesity, we examined serum cytokine levels 
in the mice (Fig. 4 G). Inflammatory cytokines RANTES/
CCL5 and TNF were increased with HFD in control mice. 
However, the levels of these chemokines were decreased in 
HFD Mgl1/ mice compared with controls. IL-10 was simi-
larly decreased in Mgl1/ mice consistent with previous 
observations (Saba et al., 2009). CCL2/MCP-1 levels were JEM VOL. 206, December 21, 2009 
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Figure 4.  Mgl1/ mice have fewer type 1 CD11c+ ATMs and decreased adipose tissue inflammation with DIO. (A and B) Expression analysis of 
inflammatory genes in adipose tissue from HFD-fed Mgl1/ and WT mice. Samples from epididymal (EWAT; A) and inguinal (IWAT; B) fat analyzed by 
real-time quantitative RT-PCR. *, P < 0.05 versus Mgl1+/+. n = 4 per group. (C) ATM content assessed by flow cytometry in HFD-fed Mgl1/ and WT mice. 
SVF cells obtained from EWAT from HFD-fed mice. Cells gated for F4/80+ ATMs and analyzed for expression of markers of type 1 (CD11c) and type 2 
(CD206) ATMs. Data shown as percentage of SVF, total cells, and normalized to tissue weight. *, P < 0.05 vs Mgl1+/+. n = 6 per group. (D) Ratio of CD11c+ 
(type 1) ATMs to CD206+ (type 2) ATMs. (E) Confocal microscopy of adipose tissue from HFD-fed Mgl1/ and control mice. Caveolin staining identifies 
intact adipocytes. Isolectin identifies CLSs and vasculature. Samples from EWAT. Bars, 50 µm. (F) Composite images from tips of EWAT fat pads stained for 
Mac2+ ATMs. Bars, 500 µm. (G) Plasma cytokine analysis from HFD-fed Mgl1/ and WT mice. n = 6 mice per group. **, P < 0.05. Samples combined from 
two independent sets of mice.3150 MGL1 and obesity-induced inflammation | Westcott et al.
Figure 5.  MGL1 is expressed on and regulates levels of 7/4hi blood monocytes. (A) Quantitation of 7/4hi and 7/4mid monocytes in blood from ND 
and HFD-fed Mgl1/ and control mice by flow cytometry. n = 12 mice per group. (B) Quantitation of 7/4hi and 7/4mid monocytes in BM from HFD-fed 
Mgl1/ and control mice by flow cytometry. n = 6 mice per group. (C) MGL1 expression in 7/4hi inflammatory monocytes. Flow cytometry performed on 
blood from male mice. 7/4hi Ly6G inflammatory monocytes (R1, gray) and 7/4mid Ly6G (R2, white) were gated and analyzed for MGL1 expression. Rep-
resentative plot shown from five independent experiments. (D) MGL1 expression in blood monocytes with HFD-induced obesity. MFI of MGL1 staining for 
monocyte subtypes in ND and HFD-fed C57BL/6 mice. Staining of Mgl1/ monocytes shows antibody specificity. n = 4 mice per group. *, P < 0.05. Data 
are representative of data combined from two to three independent sets of animals.
both time points (Fig. 6 A). Assessment of transferred cells in 
the spleen at 72 h showed equal numbers of monocytes and 
did not suggest that sequestration in the spleen explained the 
peripheral monocyte phenotype (unpublished data). This sug-
gests that Mgl1 deficiency alters the intrinsic properties of mono-
cytes that helps maintain them in the circulation.
To further assess the importance of MGL1 in promoting 
monocyte trafficking to inflammatory sites, we looked at the 
accumulation of thioglycollate (TG)-elicited peritoneal macro-
phages (PMs) in Mgl1/ mice. TGPMs had increased MGL1 
expression compared with resident PMs, consistent with other 
reports of MGL1 induction upon stimulation of migration 
(Fig. 6 B; Dupasquier et al., 2006). Analysis of the accumula-
tion of PMs after TG injection showed that Mgl1/ mice had 
fewer cells recruited 18 h after injection compared with WT 
controls (Fig. 6 C). At the 72 h time point, there was no 
significant difference between the two genotypes. Ccr2/ 
controls showed little PM recruitment after TG injection. 
In addition, TG-elicited PMs from Mgl1/ mice had decreased 
TNF expression with LPS treatment compared with controls, JEM VOL. 206, December 21, 2009 
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MGL1+ 7/4hi monocytes. Lewis X was not detected in visceral 
adipose tissue from lean mice (Fig. 7 C). However, in obese 
mice, Lewis X was detected as highly concentrated in the 
isolectin+ CLS (Fig. 7 D). This indicates that MGL1 binding 
targets are induced in CLS with DIO, which may play a role 
in 7/4hi monocyte trafficking to these regions.
DISCUSSION
Our study reveals a novel and unexpected function for the 
murine scavenger receptor MGL1 in the regulation of the 
inflammatory response to obesity. Because MGL1 is highly 
expressed in type 2 ATMs that secrete IL-10 and have low 
inflammatory activity, our initial hypothesis was that Mgl1 
knockout mice would have a higher ratio of type 1 ATMs to 
type 2 ATMs, and thus more inflammation. Surprisingly, we 
found that Mgl1/ mice are protected from HFD-induced 
insulin resistance and steatosis, which correlates with attenu-
ation of inflammatory ATM accumulation in visceral fat 
despite having larger adipocytes. The mechanism behind this 
phenotype is related to the observation that MGL1 regulates 
the properties of circulating monocytes that ultimately im-
pact the appearance of ATMs in fat. MGL1 is expressed on 
inflammatory 7/4hi monocytes in the blood, a suspected pre-
cursor of type 1 ATMs, and these cells are decreased in the 
circulation of obese animals. The absence of MGL1 alters the 
suggesting that the recruited Mgl1/ PM have less inflamma-
tory potential (Fig. 6 D). Overall, these results support a role 
for MGL1 in generating the maximal recruitment of inflam-
matory mononuclear phagocytes to sites of inflammation.
Mgl1/ monocytes demonstrate decreased adhesion  
to adipocytes in vitro and Lewis X is up-regulated  
in fat with DIO
Another property of monocytes that might explain the pro-
tection from ATM infiltration is altered interactions between 
adipocytes and MGL1-deficient monocytes. To assess this 
hypothesis, we compared the adhesion of monocytes from 
control and Mgl1/ mice to 3T3-L1 adipocytes, a well estab-
lished adipocyte cell line. In this assay, the adhesion of Mgl1/ 
monocytes was significantly decreased compared with wild 
type (Fig. 7 A). This difference was not seen when mono-
cytes were incubated with an endothelial cell line (bEnd.3) in 
the presence or absence of TNF (Fig. 7 B). This suggests that 
ligands for MGL1 are present on adipocytes and may regulate 
the trafficking and/or retention of macrophages or mono-
cytes in adipose tissue.
MGL1 binds Lewis X trisaccharides with high-affinity 
and specificity (Singh et al., 2009). This led us to hypothesize 
that the DIO would induce or alter the expression of Lewis 
X motifs in adipose tissue that might direct the trafficking of 
Figure 6.  Decreased inflammatory activity in Mgl1/ PMs. (A) Decreased half-life of Mgl1/ monocytes after adoptive transfer. Circulating 
CD11b+ monocytes were quantified in the blood 1 and 3 d after i.v. injection of 2 × 106 CFSE-labeled monocytes into C57BL/6 mice. n = 9 per group.  
(B) Quantitation of PMs after injection in Mgl1/ and control mice. Peritoneal cells were assessed 18 and 72 h after i.p. TG injection into Mgl1/, 
Ccr2/, and control mice. n = 4 mice per group. (C) MGL1 expression on TG elicited PMs. Flow cytometry for MGL1 expression on PMs isolated from mice 
with and without TG injection. Expression presented as MFI of MGL1 expression in F4/80+ cells. n = 4 per group. (D) TNF expression in macrophages from 
Mgl1/ and control mice. PMs were isolated from mice and stimulated with or without 0.1 µg/ml LPS in complete media for 6 h. Cells were stained for 
intracellular TNF expression and quantitated by MFI. n = 4 per group. All data were observed in two independent experiments.3152 MGL1 and obesity-induced inflammation | Westcott et al.
into the circulation via interactions with CCL2/MCP-1 and 
CCL7/MCP-3 (Serbina and Pamer, 2006; Tsou et al., 2007). 
Ccr2/ mice have a profound loss of 7/4hi Ly6c+ monocytes 
with preservation of circulating 7/4mid monocytes in the 
blood (Tsou et al., 2007). This translates into a lack of accu-
mulation of type 1 ATMs in obese Ccr2/ mice, the normal 
recruitment of type 2 ATMs, and protection from obesity-
induced insulin resistance (Weisberg et al., 2006; Lumeng 
et al., 2007b, 2008).
Both obese Mgl1/ mice and Ccr2/ mice demonstrate 
that attenuation of inflammatory 7/4hi Ly6c+ monocytes 
can block ATM accumulation in adipose tissue, decrease 
properties of these monocytes decreasing their survival in the 
circulation. MGL1 also participates in mediating the adhesion 
between monocytes and adipocytes, and we have identified 
Lewis X binding sites for MGL1 that are increased in adipose 
tissue with DIO.
These observations demonstrate that MGL1 is among a 
growing number of leukocyte receptors and chemokines that 
regulate the appearance and stability of monocytes in the cir-
culation. CX3CR1 regulates 7/4mid Gr-1lo monocyte num-
bers in mice by enhancing their survival in the circulation 
(Landsman et al., 2009). CCR2 is now recognized to be crit-
ical for the migration of monocytes from the bone marrow 
Figure 7.  MGL1 regulates monocyte adhesion to adipocytes. (A) Monocytes from Mgl1/ mice have decreased adhesion to adipocytes. 0.5 × 106 
CFSE-labeled monocytes were incubated with differentiated 3T3-L1 adipocytes for 30 min. After extensive washing to remove nonadherent cells, wells 
were fixed and stained with DAPI (blue). Images were analyzed by quantifying CFSE+ cells (pink) that were attached to adipocytes and normalizing this 
number to the number of adipocytes per high-power field. Eight images were analyzed from four independent experiments. *, P < 0.05. (B) Mgl1/ 
monocytes have normal adhesion to endothelial cells. After treatment of bEnd.3 monolayers with or without TNF (50 ng/ml), 0.5 × 106 CFSE-labeled 
monocyte were added to the wells. After 30 min, cells were washed and fixed. Adherent CFSE cells were quantitated by imaging at 2003. Two images 
were analyzed from each of eight independent samples, and the experiment was repeated twice. (C) Lewis X is not detected in epididymal adipose tissue 
from lean ND-fed mice. Epididymal fat pads from ND-fed C57BL/6 mice were stained with anti-Lewis X antibodies and isolectin to identify blood vessels. 
(D) Lewis X is highly expressed in CLS in visceral adipose tissue from obese HFD-fed mice. Epididymal fat pads from HFD-fed C57BL/6 mice were stained 
with anti-Lewis X antibodies and isolectin to identify blood vessels. Representative images are shown. Similar results were obtained from three indepen-
dent samples. Bars, 50 µm.JEM VOL. 206, December 21, 2009 
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ferences may also be caused by other sources of IL-10 such as 
newly identified adipose tissue regulatory T cells (Feuerer 
et al., 2009).
We also found that MGL1-deficient monocytes had de-
creased adhesion to adipocytes in vitro which can contribute 
to the significant decrease in type 1 ATM accumulation in 
obese Mgl1/ mice. Less efficient binding of the Mgl1/ 
7/4hi monocytes to adipocytes may work in concert with 
their lower levels to attenuate inflammation. Although gly-
can arrays have shown that MGL1 binds to Lewis X and 
Lewis A trisaccharides, the full range of binding partners in 
vivo has yet to be revealed. We speculated that DIO and hy-
perglycemia promote the formation of a Lewis X containing 
ligands for MGL1 and observed the induction of Lewis X 
expression in CLS with DIO, an observation that may pro-
vide a means for circulating MGL1+ 7/4hi monocytes to traf-
fic to CLS.
We did not find evidence that other lectin receptors such 
as MGL2 or CD206 are up-regulated in macrophages in re-
sponse to MGL1 deficiency. Human MGL promotes interac-
tions between DCs and endothelial cells that inhibit migration 
and promote retention of DCs in lymphoid organs (van Vliet 
et al., 2008b). Glycosylation-dependent interactions between 
leukocytes and endothelial cells play a significant role in the 
recruitment of inflammatory cells to atherosclerotic plaques 
via interactions between PSGL-1 and P-selectin (Lowe, 2003; 
Martinez et al., 2005). Our observations with Lewis X are 
consistent with these observations, and the report of altera-
tions in glycosylation at Lewis X residues on 1-acid glyco-
protein in type I diabetes (Poland et al., 2001). Further studies 
will be needed to assess if mMGL1, mMGL2, or hMGL are 
potential targets for inhibitors that could specifically target 
the obesity-induced trafficking of inflammatory monocytes and 
attenuate the formation of type 1 ATMs.
We have identified ST2 as a novel marker of type 2 ATMs. 
The expression of this receptor can inhibit signaling from 
TLR receptors suggesting another mechanism by which type 2 
ATMs maintain a suppressed inflammatory state. Lack of ST2 
in type 1 ATMs may help maintain proinflammatory signals 
from TLR4 activated by free fatty acids that are concentrated 
in adipose tissue (Shi et al., 2006; Nguyen et al., 2007; Coenen 
et al., 2009).
We have previously referred to ATM subtypes as M1 and 
M2 ATMs; however, this is imprecise and likely overly sim-
plistic because these states were defined in vitro (Gordon and 
Taylor, 2005). Additionally, how the “M1/M2 paradigm” 
relates to human macrophages is still unclear (Zeyda et al., 
2007; Bourlier et al., 2008). We propose a new nomenclature 
for these ATM subtypes: type 1 ATMs are F4/80+ MGL1 
CD206 ST2 CD11c+ and are concentrated in CLS. These 
ATMs express many genes seen in classically activated M1 
macrophages. Type 2 ATMs are F4/80+ MGL1+ CD206+ 
ST2+ CD11c and represent the resident ATM population 
localized to interstitial spaces between adipocytes. These cells 
express many, but not all, markers of alternatively activated M2 
macrophages. This redefinition leaves room to define new 
obesity-induced inflammation in fat, and improve glucose tol-
erance. These observations provide added support to a model 
where differential trafficking of monocyte subpopulations gen-
erates the increased ratio of type 1 to type 2 and the “pheno-
typic switch” to a proinflammatory environment with obesity. 
Our results suggest that a critical nexus of interaction be-
tween obesity and inflammation may reside at the level of circu-
lating monocytes,  and  support  the  results  of  other  studies 
showing activation of peripheral monocytes in obesity (Ghanim 
et al., 2004; Degasperi et al., 2009). This perspective suggests 
that the elevations in circulating CCL2/MCP-1 seen in obe-
sity and type 2 diabetes (Sartipy and Loskutoff, 2003; Takahashi 
et al., 2003) may in fact play a primary role in promoting 
egress of inflammatory monocytes from the bone marrow 
into the circulation, rather than just the recruitment of these 
cells from the circulation into adipose tissue. Redundant signals 
from CCL2 and CCL7 to promote the migration of CCR2+ 
monocytes from the bone marrow could explain why exami-
nation of ATMs in obese Ccl2/ mice has led to variable re-
sults (Kanda et al., 2006; Inouye et al., 2007; Kirk et al., 2008).
Evaluation of glucose metabolism in obese Mgl1/ mice 
demonstrates a significant protection from insulin resistance 
and type 1 ATM accumulation that is out of proportion to 
the modest difference in body weight observed. It is possible 
that differences in glucose metabolism observed are caused 
by the slight weight loss seen in the Mgl1/ mice. How-
ever, Mgl1/ mice actually have more visceral adipose tis-
sue than controls with DIO, which is partially caused by 
larger adipocytes. The unique dissociation between adipos-
ity and glucose intolerance is associated with a profound lack 
of ATM infiltration in Mgl1/ mice, further supporting a 
primary role for ATMs in the regulation of glucose metabo-
lism. The deficiency of type 1 ATMs in the knockout mice 
results  in  more  intact  adipocytes,  improved  triglyceride 
storage in fat, decreased circulating FFA, and protection from 
hepatic steatosis.
These observations emphasize a property of adipose tissue 
that is still poorly understood: how visceral adipose tissue 
expansion may actually be metabolically beneficial in certain 
contexts. This agrees with recent observations that overex-
pression of adiponectin in leptin-deficient animals led to adi-
pose tissue expansion without inflammation and maintained 
insulin sensitivity despite profound obesity (Kim et al., 2007).
Composite images (Fig. 4 F) demonstrate that the ATM 
accumulation with DIO is not uniform as CLS are distributed 
in patches. This regional variation in ATM accumulation may 
explain the variation in RT-PCR analysis of gene expression 
in small fat biopsy samples. Our observation of increased 
IL-10 expression and a decrease in the ratio of type 1 to type 2 
ATMs in visceral fat from obese Mgl1/ mice provides 
further support for the idea that ATM activation state is an 
important variable in the generation of adipose tissue inflam-
mation. Changes in IL-10 were not observed in subcutane-
ous fat in the knockout animals which may be caused by the 
fact that type 1 ATMs do not accumulate in this depot as sig-
nificantly as in visceral fat (Lumeng et al., 2007b). Such dif-3154 MGL1 and obesity-induced inflammation | Westcott et al.
with 10% heat-inactivated fetal bovine serum (Invitrogen). 3T3-L1 adipo-
cytes were grown and differentiated as previously described (Baumann et al., 
2000). For in vitro adhesion assays, 0.5 × 106 CFSE-labeled monocytes from 
either genotype were added to differentiated adipocytes or confluent bEnd.3 
monolayers in 12-well dishes for 30 min at 37°C. In some experiments, 
bEnd.3 cells were treated for 3 h with 50 ng/ml recombinant TNF (Sigma-
Aldrich)  before  the  addition  of  monocytes.  After  adhesion,  wells  were 
washed three times in PBS, and then fixed in 10% formalin. Adherent cells 
were quantitated after DAPI staining and imaging at 200× to enumerate 
monocytes in direct contact with adipocytes and normalized to the number 
of adipocytes per high power field.
Adoptive transfer of labeled monocytes. Monocytes were isolated from 
single-cell suspensions from spleen by Ficoll gradient (GE Healthcare). After 
washing, cells were labeled with by incubation with 5 µM CFSE in PBS and 
quenched with serum containing media. After washing in PBS, cells were 
counted and 2 × 106 cells were injected I.V. (retroorbital) in 200 µl total 
volume. 24 and 72 h after injection, blood was obtained by tail bleed in hep-
arinized capillary tubes and stained for flow cytometry after erythrocyte lysis. 
CFSE+ 7/4hi CD11b+ cells in the monocyte gate were quantitated and ex-
pressed as a percentage of all 7/4hi CD11b+ cells.
Statistical  analysis. Statistical comparisons made using Student’s t tests 
with significance defined as a P value <0.05. Graphs presented as mean and 
errors bars represent standard error of the mean.
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